26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

628<br />

Chapter | 20 Thyroid Function<br />

A direct effect <strong>of</strong> thyroid hormones on cell membrane<br />

transport has also been suggested from studies on 2-deoxyglucose<br />

uptake ( Segal et al. , 1977 ). Pliam and Goldfine<br />

(1977) proposed that T 3 binds to receptors on the cell membrane<br />

and is transported by carriers into the cell.<br />

A combination <strong>of</strong> the aforementioned mechanisms is<br />

the most likely explanation <strong>of</strong> the mechanism <strong>of</strong> action <strong>of</strong><br />

thyroid hormone. A viable model patterned after the generalized<br />

steroid hormone model is one in which (1) T 3 is<br />

bound to a receptor site on the plasma membrane, (2) T 3 is<br />

transported across the membrane into the cell by the carrier<br />

protein, (3) T 3 in the cell is again bound to a carrier<br />

protein, (4) T 3 rapidly exchanges between receptor sites on<br />

the mitochondrion or nucleus, and (5) T 3 interacts in metabolic<br />

processes and protein synthesis.<br />

VIII . CATABOLISM AND EXCRETION OF<br />

THYROID HORMONES<br />

The thyroid hormones undergo deiodination, conjugation,<br />

or oxidative reactions. The deiodination reaction occurs<br />

widely in peripheral tissues and is catalyzed by deiodinases<br />

specific for each iodine position, and the released iodine is<br />

returned to the iodine pool. The details <strong>of</strong> the specific reactions,<br />

however, are not yet known. The deiodinase that catalyzes<br />

the deiodination <strong>of</strong> T 4 to T 3 in target cells is actually<br />

participating in an activation reaction. Deiodination at the<br />

3 position <strong>of</strong> T 4 gives rT 3 , the inactive form on the degradation<br />

pathway. Within a cell, therefore, some <strong>of</strong> the T 4<br />

is converted to its active form, and some is converted to<br />

its inactive form for degradation. Some <strong>of</strong> the thyroid hormones<br />

are conjugated in the liver and excreted in the bile<br />

either as glucuronides or as sulfates. Also, the thyroid hormones,<br />

being amino acids, are deaminated and decarboxylated<br />

in the liver to form corresponding tetraiodoacetic acid<br />

and tri-iodoacetic acid, which are excreted by the kidney.<br />

Finally, the kidney also excretes the small amounts <strong>of</strong> free<br />

hormones in the blood.<br />

IX . REGULATION OF THE THYROID GLAND<br />

A . Production and Regulation <strong>of</strong> Thyroid-<br />

Stimulating Hormone<br />

The thyroid gland is under the control <strong>of</strong> the thyroidstimulating<br />

hormone (TSH), which is secreted by the anterior<br />

pituitary gland, which in turn is mediated through the<br />

hypothalamus and its thyrotropin-releasing hormone (TRH).<br />

The TRH is synthesized in the anterior hypothalamus by<br />

neurosecretory cells and then transported down axonic processes<br />

to the anterior pituitary. There, TRH stimulates the<br />

thyrotrophic cells to synthesize TSH. The secretion <strong>of</strong> TSH<br />

is regulated by a classic negative feedback control system<br />

based on the product <strong>of</strong> the target gland, thyroxine. A high<br />

plasma concentration <strong>of</strong> free hormone, fT 4 , depresses TSH<br />

secretion by the pituitary and, to some extent, the TRH<br />

from the hypothalamus. The direct inhibition <strong>of</strong> the pituitary<br />

by increased fT 4 is the faster responding <strong>of</strong> the two<br />

tissues. At low concentrations <strong>of</strong> fT 4 , however, the hypothalamus<br />

responds quickly by increasing its synthesis and<br />

release <strong>of</strong> TRH, which in turn increases the synthesis and<br />

release <strong>of</strong> pituitary TSH. In consequence, this regulatory<br />

mechanism, which is sensitive to either high or low concentrations<br />

<strong>of</strong> fT 4 , maintains the circulatory hormone concentrations<br />

at the normal homeostatic level for that species.<br />

B . Action <strong>of</strong> the Thyroid-Stimulating<br />

Hormone on the Thyroid Gland<br />

TSH has a number <strong>of</strong> direct effects on the thyroid gland:<br />

the gland increases in size, the height <strong>of</strong> the follicular cell<br />

increases, and there is a loss <strong>of</strong> colloid. The response <strong>of</strong><br />

the thyroid gland to TSH is modified by the intake <strong>of</strong> stable<br />

iodine. When iodine intake is high, the action <strong>of</strong> TSH<br />

is suppressed and the height, size, and activity <strong>of</strong> the follicular<br />

cells decrease. When iodine intake is low, there is a<br />

compensatory hypertrophy <strong>of</strong> the gland with an increase in<br />

number, height, and size <strong>of</strong> the follicular cells. This is characteristic<br />

<strong>of</strong> the iodine deficiency goiters or the nontoxic<br />

goiters.<br />

C . Action <strong>of</strong> the Thyroid-Stimulating<br />

Hormone on Hormonogenesis<br />

The effects <strong>of</strong> TSH on hormone synthesis by the thyroid follicle<br />

are outlined in Figure 20-1 and discussed in Section V.<br />

TSH affects every reaction in the hormone synthetic pathway<br />

beginning with the uptake <strong>of</strong> iodine, its activation,<br />

tyrosine iodination, coupling <strong>of</strong> the iodinated phenyls, and<br />

hydrolysis <strong>of</strong> colloid. The two most important sites <strong>of</strong> TSH<br />

action are the initial uptake <strong>of</strong> iodine and the final hydrolysis<br />

<strong>of</strong> colloid to release hormones into the circulation.<br />

D . Long-Acting Thyroid Stimulators<br />

A second thyroid stimulatory factor has been identified<br />

in the serum <strong>of</strong> human patients with Graves ’ disease and<br />

appears to be closely involved in the mechanism <strong>of</strong> thyrotoxicosis<br />

( Adams, 1958 ). It differs from TSH in that it<br />

is cleared from the blood more slowly and produces its<br />

thyroid-stimulating effects many hours (8 to 24) after that<br />

<strong>of</strong> TSH. It is therefore referred to as long-acting thyroid<br />

stimulator, or LATS. Studies <strong>of</strong> LATS have been largely in<br />

humans where it has been closely correlated with hyperthyroidism<br />

( Lipman et al. , 1967 ). Since the initial observations,<br />

many other forms <strong>of</strong> delayed-acting thyroid<br />

stimulators have been found, and all, including LATS, are<br />

now known to be immunoglobulins <strong>of</strong> the IgG class. These

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!